1. Market Research
  2. > Pharmaceutical
  3. > Biopharmaceutical Market Trends
Middle East and Africa Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapy Type ; Product ; Technology ; Application ; End User and Country

Middle East and Africa Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapy Type ; Product ; Technology ; Application ; End User and Country

  • February 2021
  • 129 pages
  • ID: 6027813
  • Format: PDF
  • The Insight Partners
Up to $1000 off Until Apr 30th 2021


Table of Contents

Search Inside

The Middle East and Africa cell therapy market is expected to reach US$ 346.7 million by 2027 from US$ 234.4 million in 2019; it is anticipated to grow at a CAGR of 5.1% during 2019-2027.
The Middle East and Africa cell therapy market is growing primarily due to increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and growing number of approvals for cell-based therapies. Factors such as high cost of cell therapy manufacturing restraining the growth of the market.
Mainly stem cells are used for cell therapies because of their ability to differentiate specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy also has applications in the development of regenerative medicines.
The Middle East & Africa is hindered due to the burden of chronic diseases owing to the lack of proper healthcare system across the region and low awareness about the novel therapeutics available in the market. National Institute of Health of South Africa has reported that around 5.7 million people in the country were suffering from HIV, during 2016-2017. Network of Civil Society Organizations also reported that South Africa is experiencing the surge in the number of patients suffering from Noncommunicable Diseases (NCDs) such as heart diseases, stroke, cancer, diabetes, and chronic lung disease. According to the International Diabetes Federation (IDF) Diabetes Atlas 8th Edition, around 15.5 million adults of aged 20-79 years were having diabetes in Africa in 2017. According to Globocan 2018, prevalence for cervical cancer is around 11.3 %, i. e 119,284 cases have been registered in Africa in 2018. With such a huge patient pool and a huge scope of the market, many major players in the cell therapy market are investing in the region.
Similarly in the UAE, there is a high prevalence of diabetes. According to the International Diabetes Federation (IDF), 17.3% of the UAE population between the age of 20 and 79 years was suffering from type 2 diabetes in 2017. Over 1 million people are affected by diabetes in the UAE, placing the country at the 15th rank in the world for diabetic prevalence. According to the Department of Health Abu Dhabi, cancer is the third leading cause of death in Abu Dhabi and accounts for 16 % of total deaths.
The COVID-19 pandemic has become the most significant challenge across the Middle East and Africa.Countries such as the UAE and Saudi Arabia have also registered a significant number of positive patients.

In the initial phase of lockdown, various countries have witnessed disruptions in the supply of many instruments across the regions.Therefore, many organizations are collaborating with others to overcome this pandemic by using cell therapies in the treatment of COVID 19.

For instance, UAE-based Abu Dhabi Stem Cells Center (ADSCC) has entered into collaboration agreement with Pluristem Therapeutics Inc. to develop cell therapies and regenerative medicines for the treatment of COVID-19.
In 2019, the allogeneic segment accounted for a larger share of the Middle East and Africa cell therapy market.The growth of the market for this segment is attributed to the factors such as increasing number of product launch to accelerate the overall product availability for stem therapy using allogeneic stem cell therapeutics.

However, the autologous segment is likely to register a higher CAGR in the market during the forecast period.
A few of the significant secondary sources referred to while preparing the report on the Middle East and Africa cell therapy market are the World Health Organization (WHO), Centers of Disease Control and Prevention (CDC), National Institute of Health of South Africa, and Department of Health Abu Dhabi, Abu Dhabi Stem Cell Center (ADSCC).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Asia Pacific Single-cell Analysis Market by Cell Type, Product, Technique, Application, End User - Forecast to 2025

  • $ 4950
  • January 2021
  • 208 pages

The Asia Pacific single-cell analysis market is projected to reach USD 1,375 million by 2025 from USD 550 million in 2020, at a CAGR of 20.1% during the forecast period. Market growth is driven by factors ...

  • APAC
  • Cell Therapy
  • Industry analysis
  • Cancer Incidence
  • Infectious Disease Incidence


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on